POET Technologies (POET) had the highest return between February 1, 2018 and March 8, 2018 by a small-cap US stock, returning 130.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
POET Technologies (POET) | 2/1/2018 - 3/8/2018 | 130.43% |
Nutex Health (NUTX) | 2/1/2018 - 3/8/2018 | 85% |
American Public Education (APEI) | 2/1/2018 - 3/8/2018 | 58.89% |
Vericel Corp Ord (VCEL) | 2/1/2018 - 3/8/2018 | 52.26% |
Liquidity Services (LQDT) | 2/1/2018 - 3/8/2018 | 45.92% |
Know Labs (KNW) | 2/1/2018 - 3/8/2018 | 45.41% |
Tandem Diabetes Care (TNDM) | 2/1/2018 - 3/8/2018 | 45.16% |
Xencor (XNCR) | 2/1/2018 - 3/8/2018 | 40.89% |
Gravity (GRVY) | 2/1/2018 - 3/8/2018 | 40.29% |
PAR Technology (PAR) | 2/1/2018 - 3/8/2018 | 37.62% |
Transcontinental Realty Investors (TCI) | 2/1/2018 - 3/8/2018 | 36.96% |
InnovAge (INNV) | 2/1/2018 - 3/8/2018 | 36.72% |
Regenxbio (RGNX) | 2/1/2018 - 3/8/2018 | 36.21% |
Dine Brands Global (DIN) | 2/1/2018 - 3/8/2018 | 36.19% |
Astria Therapeutics (ATXS) | 2/1/2018 - 3/8/2018 | 35.33% |
Spyre Therapeutics (SYRE) | 2/1/2018 - 3/8/2018 | 33.48% |
Arq (ARQ) | 2/1/2018 - 3/8/2018 | 33.23% |
Paysign (PAYS) | 2/1/2018 - 3/8/2018 | 32% |
Pangaea Logistic (PANL) | 2/1/2018 - 3/8/2018 | 31.27% |
Nektar Therapeutics (NKTR) | 2/1/2018 - 3/8/2018 | 30.68% |
Cronos (CRON) | 2/1/2018 - 3/8/2018 | 30.5% |
Criteo (CRTO) | 2/1/2018 - 3/8/2018 | 29.15% |
Intellia Therapeutics (NTLA) | 2/1/2018 - 3/8/2018 | 28.17% |
Scpharmaceuticals (SCPH) | 2/1/2018 - 3/8/2018 | 27.98% |
Cimpress (CMPR) | 2/1/2018 - 3/8/2018 | 26.87% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
